Using the ProFoundry platform and Novartis' expertise, the partners will identify novel proteins and drug targets for cardiovascular disease.

Labviva connects pharmaceutical R&D labs directly to 90% of all raw materials suppliers available in the United States and Europe.

ISS-based lab-on-a-chip model advances the understanding of muscle aging and degeneration in microgravity, guiding future therapeutic strategies.

When the macrophages’ ability to consume dying cancer cells or Upd3 production was decreased, tumor growth was significantly ...

The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts ...

The company has integrated the AI model into its internal discovery pipeline and aims to use it in collaborative drug ...